The information in this preliminary prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
SUBJECT TO COMPLETION, DATED NOVEMBER 5, 2021
$235,000,000
Europa Growth Acquisition Company
23,500,000 Units
Europa Growth Acquisition Company is a newly incorporated blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, which we refer to as our initial business combination. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. While we may pursue an initial business combination target in any sector or industry (subject to certain limitations described herein), we intend to focus our search for a target business in Europe and on a business that focuses on digital or green transformation in the financial services or environmental sectors.
This is an initial public offering of our securities. Each unit has an offering price of $10.00 and consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment, terms and limitations as described herein. The underwriter has a 45-day option from the date of this prospectus to purchase up to 3,525,000 additional units to cover over-allotments, if any.
We will provide our public shareholders with the opportunity to redeem all or a portion of their Class A ordinary shares upon the completion of our initial business combination, subject to the limitations as described herein. If we have not consummated an initial business combination within 15 months from the closing of this offering (or up to 21 months from the closing of this offering, if our time to complete a business combination is extended as described herein), we will redeem 100% of the public shares for cash, subject to applicable law and certain conditions as described herein.
Eleven (11) qualified institutional buyers or institutional accredited investors that are not affiliated with us, our sponsor, our directors or any member of our management team, which we collectively refer to as our anchor investors throughout this prospectus, have collectively expressed to us an interest in purchasing up to an aggregate of 23,852,500 units in this offering at the offering price. We have agreed to direct the underwriters to offer to our anchor investors such units, and determine the allocations of units to anchor investors, provided that the number of units sold to anchor investors may be reduced if our anchors expressions of interest exceed the size of this offering and to ensure that sufficient units are held by all of our shareholders in order to meet the minimum listing standards of the Nasdaq Global Market. There can be no assurance that our anchor investors will acquire any units in this offering, or as to the amount of such units our anchor investors will retain, if any, prior to or upon the consummation of our initial business combination. There is also no guarantee that all eleven (11) anchor investors will participate in the offering. For a discussion of certain additional arrangements with our anchor investors, see “Summary—The Offering—Expressions of Interest and Anchor Agreements.”
Our sponsor, EGA Sponsor LLC, a Cayman Islands limited liability company, has agreed to purchase an aggregate of 2,642,999 warrants (or 3,230,499 warrants if the underwriter’s over-allotment option is exercised in full), at a price of $1.50 per warrant in a private placement to occur concurrently with the closing of this offering for an aggregate purchase price of $3,964,498 (or $4,845,748 if the over-allotment option is exercised in full) that will close simultaneously with the closing of this offering. In addition, on November 5, 2021, two of our director nominees and a member of our advisory board agreed to purchase an aggregate of 2,250,000 private placement warrants from us at a price of $1.50 per warrant in a private placement to occur concurrently with the closing of this offering. Six of our anchor investors have agreed to purchase from us an aggregate of 823,668 warrants at a price of $1.50 per warrant on the closing date of this offering for an aggregate purchase price of $1,235,500. If an anchor investor indicates to our underwriter an offer to purchase less than the number of units that such anchor investor has expressed an interest in purchasing (excluding any exercise of the underwriter’s over-allotment option), then such anchor investor’s allocation of private placement warrants will be reduced to zero (0) and 100% of the purchase price will be returned to such investor. To the extent our anchor investors do not purchase units for which they have indicated an interest in purchasing, our sponsor has agreed to purchase the warrants that are not purchased by our anchor investors. If the actual number of units offered and sold in this offering is less than 18,800,000 or greater than 28,200,000, our anchor investors will have the right to terminate their agreements to purchase private placement warrants from us. Each private warrant is identical to the public warrants sold in this offering, subject to certain exceptions as described in this prospectus.
Our initial shareholders currently own 6,756,250 Class B ordinary shares (up to 881,250 of which are subject to forfeiture depending on the extent to which the underwriter does not exercise its over-allotment option), which will automatically convert into Class A ordinary shares at the time of our initial business combination, as described herein. Prior to the completion of our initial business combination, only holders of our Class B ordinary shares will be entitled to vote on the appointment of directors. Our anchor investors have agreed to purchase from our sponsor an aggregate of 1,969,887 of our Class B ordinary shares at a price of $0.004 per share on the closing date of this offering. If an anchor investor indicates to our underwriter an offer to purchase less than the number of units that such anchor investor has expressed an interest in purchasing (excluding any exercise of the underwriter’s over-allotment option), then such anchor investor’s allocation of Class B ordinary shares will be reduced to zero (0) and 100% of the purchase price will be returned to such investor. If the actual number of units offered and sold in this offering is less than 18,800,000 or greater than 28,200,000, our anchor investors will have the right to terminate their agreements to purchase Class B ordinary shares from us. Of the proceeds from the sale of the private placement warrants an additional $1,175,000, or $1,351,250 if the underwriter’s over-allotment option is exercised in full, will be deposited into the trust, such that the trust is over-funded by 0.5% of the proceeds raised in this offering.
Currently, there is no public market for our securities. We have applied to have our units listed on the Nasdaq Global Market, or Nasdaq, under the symbol “EGACU.” We cannot guarantee that our securities will be approved for listing on Nasdaq. We expect the Class A ordinary shares and warrants comprising the units to begin separate trading on Nasdaq under the symbols “EGAC” and “EGACW,” respectively, on the 52nd day following the date of this prospectus unless Barclays Capital Inc. informs us of its decision to permit earlier separate trading and we have satisfied certain conditions described herein. At the time that the Class A ordinary shares and warrants comprising the units begin separate trading, holders will hold the separate securities and no longer hold units (without any action needing to be taken by the holders), and the units will no longer trade or be listed on Nasdaq.
We are an “emerging growth company” and “smaller reporting company” under applicable federal securities laws and will be subject to reduced public company reporting requirements. Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page 45 for a discussion of information that should be considered in connection with an investment in our securities. Investors will not be entitled to protections normally afforded to investors in Rule 419 blank check offerings.
Neither the U.S. Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
| | | | | | | | |
| | Per Unit | | | Total | |
Public offering price | | $ | 10.00 | | | $ | 235,000,000 | |
Underwriting discounts and commissions(1) | | $ | 0.55 | | | $ | 12,925,000 | |
Proceeds, before expenses, to us | | $ | 9.45 | | | $ | 222,075,000 | |
(1) | Includes $0.35 per unit, or $8,225,000 in the aggregate (or $9,458,750 in the aggregate if the underwriter’s over-allotment option is exercised in full), payable to the underwriter for deferred underwriting commissions to be placed in a trust account located in the United States as described herein and released to the underwriter only upon the consummation of an initial business combination. Does not include certain fees and expenses payable to the underwriter in connection with the offering. See also “Underwriting” for a description of underwriting compensation payable to the underwriter. |
Of the proceeds we receive from this offering and the sale of the private placement warrants described in this prospectus, $236,175,000, or $271,601,250 if the underwriter’s over-allotment option is exercised in full ($10.05 per unit in either case), will be deposited into a trust account located in the United States with Continental Stock Transfer & Trust Company acting as trustee.
The underwriter is offering the units for sale on a firm commitment basis. The underwriter expects to deliver the units to the purchasers on or about , 2021.
Book-Running Manager
Barclays
The date of this prospectus is , 2021.